Author:
Kiso Maki,Uraki Ryuta,Ito Mutsumi,Yamayoshi Seiya,Kotani Yoshifumi,Imai Masaki,Kohda Noriyuki,Kawaoka Yoshihiro
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing coronavirus pandemic. Besides vaccines and antiviral drugs, probiotics have attracted attention for prevention of SARS-CoV-2 infection. Here, we examined the efficacy of heat-killed Lactiplantibacillus pentosus ONRICb0240 (b240) against SARS-CoV-2 infection in mice. We observed that oral intake of heat-killed b240 did not affect virus titers in the respiratory organs of SARS-CoV-2-infected mice, but did provide partial protection against SARS-CoV-2 infection. In addition, heat-killed b240 treatment suppressed the expression of IL-6, a key proinflammatory cytokine, on Day 2 post-infection. Our results highlight the promising protective role of heat-killed b240 and suggest a possible mechanism by which heat-killed b240 partially protects against SARS-CoV-2 infection by modulating host responses.
Funder
Japan Agency for Medical Research and Development
Reference33 articles.
1. COVID-19 treatment-current status, advances, and gap;Ho;Pathogens,2022
2. COVID-19 therapeutics: Challenges and directions for the future;Robinson;Proc Natl Acad Sci USA,2022
3. Probiotics in Food: Health and Nutritional Properties and Guidelines for Evaluation. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria,2006
4. Role of probiotics to combat viral infections with emphasis on COVID-19;Sundararaman;Appl Microbiol Biotechnol,2020
5. Emerging trends in “Smart probiotics”: Functional consideration for the development of novel health and industrial applications;El Hage;Front Microbiol,2017